Defects in the production of certain receptors are linked to the pathogenesis of genetic epilepsies and fever-induced seizures.

A person’s mitochondrial gene “signature” could predict risk for diabetic retinopathy and guide early intervention strategies.

Vanderbilt investigators identify a new therapeutic target for the inflammatory lung disease sarcoidosis.

Exposure of male mice to the pollutant dioxin causes preterm birth across multiple generations, suggesting that efforts to prevent preterm birth should include pre-conception interventions for dads.

Stem cells derived from patients with pulmonary arterial hypertension provide a unique resource for studying the molecular defects that cause the disease and testing potential therapies.

Drugs developed at Vanderbilt could provide a new way to treat schizophrenia in a personalized way.

A combination treatment delivered to the site of fractures may improve bone healing in patients with the genetic disease neurofibromatosis type-1.